共 7 条
[1]
Angiotensin II Induces Interleukin-6 in Humans Through a Mineralocorticoid Receptor–Dependent Mechanism[J] . James M. Luther,James V. Gainer,Laine J. Murphey,Chang Yu,Douglas E. Vaughan,Jason D. Morrow,Nancy J. Brown.Hypertension . 2006 (6)
[2]
Blockade of the renin–angiotensin–aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes[J] . Michel Burnier,Anne Zanchi.Journal of Hypertension . 2006 (1)
[3]
Local Renal Aldosterone System and Its Regulation by Salt, Diabetes, and Angiotensin II Type 1 Receptor[J] . Chun Xue,Helmy M. Siragy.Hypertension . 2005 (3)
[4]
Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease
[J].
AMERICAN JOURNAL OF HYPERTENSION,
2005, 18 (01)
:44-49
Sato, A
;
Hayashi, K
;
Saruta, T
.
[5]
Dual Blockade of the Renin-angiotensin-aldosterone System in Diabetic Nephropathy: The Role of Aldosterone[J] . K. Schjoedt,P. Jacobsen,K. Rossing,F. Boomsma,H. Parving.Horm Metab Res . 2005 (S 1)
[6]
Aldosterone and anti-aldosterone effects in cardiovascular diseases and diabetic nephropathy
[J].
DIABETES & METABOLISM,
2004, 30 (04)
:311-318
Ambroisine, ML
;
Milliez, P
;
Nehme, J
;
Pasquier, AL
;
De Angelis, N
;
Mansier, P
;
Swynghedauw, B
;
Delcayre, C
.
[7]
Low plasma aldosterone despite normal plasma renin activity in uncomplicated type 1 diabetes mellitus: effects of RAAS stimulation[J] . P. T.Luik,M. N.Kerstens,K.Hoogenberg,G. J.Navis,R. P. F.Dullaart.European Journal of Clinical Investigation . 2003 (9)